9Efiksson R, Aagaard L, Jensen L J, et al. Discrepancies in listed adverse drug reactions in pharmaceutical product information sup- plied by the regulatory authorities in Denmark and the USA [ J ]. Pharmaeol Res Perspeet, 2014, 2(3) : 38.
10Agundez J A, Esguevillas G, Amo G, et al. Pharmacogenomics testing for type B adverse drug reactions to anti-infective drugs: the example of hypersensitivity to abacavir[ J]. Recent Pat Anti- infect Drug Discov, 2014, 9(2) : 151.
